6PL3 image
Deposition Date 2019-06-30
Release Date 2019-09-04
Last Version Date 2024-03-13
Entry Detail
PDB ID:
6PL3
Keywords:
Title:
TRK-A IN COMPLEX WITH LIGAND 2a
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.27
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 31 1 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:High affinity nerve growth factor receptor
Gene (Uniprot):NTRK1
Chain IDs:A
Chain Length:311
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA).
Bioorg.Med.Chem.Lett. 29 126624 126624 (2019)
PMID: 31444087 DOI: 10.1016/j.bmcl.2019.126624

Abstact

In silico virtual screening using the ligand-based ROCS approach and the commercially purchasable compound collection from the ZINC database resulted in the identification of distinctly different and novel acetamide core frameworks with series representatives 1a and 2a exhibiting nanomolar affinity in the kinase domain only hTrkA HTRF biochemical assay. Additional experimental validation using the Caliper technology with either the active or inactive kinase conditions demonstrated the leads, 1a and 2a, to preferentially bind the kinase inactive state. X-ray structural analysis of the kinase domain of hTrkA…1a/2a complexes confirmed the kinase, bind the inhibitor leads in the inactive state and to exhibit a type 2 binding mode with the DFG-out and αC-helix out conformation. The leads also demonstrated sub-micromolar activity in the full length hTrkA cell-based assay and selectivity against the closely related hTrkB isoform. However, the poor microsomal stability and permeability of the leads is suggestive of a multiparametric lead optimization effort requirement for further progression.

Legend

Protein

Chemical

Disease

Primary Citation of related structures